Compass Pathways Plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as … Read more
Compass Pathways Plc (CMPS) - Net Assets
Latest net assets as of September 2025: $37.59 Million USD
Based on the latest financial reports, Compass Pathways Plc (CMPS) has net assets worth $37.59 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($255.61 Million) and total liabilities ($218.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $37.59 Million |
| % of Total Assets | 14.71% |
| Annual Growth Rate | N/A |
| 5-Year Change | -21.3% |
| 10-Year Change | N/A |
| Growth Volatility | 883.44 |
Compass Pathways Plc - Net Assets Trend (2018–2024)
This chart illustrates how Compass Pathways Plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Compass Pathways Plc (2018–2024)
The table below shows the annual net assets of Compass Pathways Plc from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $154.69 Million | -31.47% |
| 2023-12-31 | $225.74 Million | +24.53% |
| 2022-12-31 | $181.28 Million | -36.26% |
| 2021-12-31 | $284.41 Million | +44.69% |
| 2020-12-31 | $196.56 Million | +2207.60% |
| 2019-12-31 | $8.52 Million | +159.28% |
| 2018-12-31 | $-14.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Compass Pathways Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 51677900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $702.00K | 0.45% |
| Other Comprehensive Income | $-16.19 Million | -10.47% |
| Other Components | $704.92 Million | 455.68% |
| Total Equity | $154.69 Million | 100.00% |
Compass Pathways Plc Competitors by Market Cap
The table below lists competitors of Compass Pathways Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Comture Corporation
PINK:CMTUF
|
$444.88 Million |
|
Shenzhen Worldunion Properties Consultancy Inc
SHE:002285
|
$444.90 Million |
|
Citic Guoan Wine Co Ltd
SHG:600084
|
$445.00 Million |
|
Hanon Systems
KO:018880
|
$445.05 Million |
|
Citra Marga Nusaphala Persada
JK:CMNP
|
$444.59 Million |
|
China Bills Finance Corp
TW:2820
|
$444.53 Million |
|
Ningxia Building Materials Group Co Ltd
SHG:600449
|
$444.49 Million |
|
Finolex Industries Limited
NSE:FINPIPE
|
$444.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Compass Pathways Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 225,744,000 to 154,695,000, a change of -71,049,000 (-31.5%).
- Net loss of 155,122,000 reduced equity.
- New share issuances of 26,219,000 increased equity.
- Other comprehensive income increased equity by 732,000.
- Other factors increased equity by 57,122,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-155.12 Million | -100.28% |
| Share Issuances | $26.22 Million | +16.95% |
| Other Comprehensive Income | $732.00K | +0.47% |
| Other Changes | $57.12 Million | +36.93% |
| Total Change | $- | -31.47% |
Book Value vs Market Value Analysis
This analysis compares Compass Pathways Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.64x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-2.56 | $6.06 | x |
| 2019-12-31 | $0.39 | $6.06 | x |
| 2020-12-31 | $5.47 | $6.06 | x |
| 2021-12-31 | $7.11 | $6.06 | x |
| 2022-12-31 | $4.27 | $6.06 | x |
| 2023-12-31 | $4.42 | $6.06 | x |
| 2024-12-31 | $2.29 | $6.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Compass Pathways Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -100.28%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.38x
- Recent ROE (-100.28%) is below the historical average (-69.95%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-11.78 Million |
| 2019 | -230.24% | 0.00% | 0.00x | 3.80x | $-20.46 Million |
| 2020 | -30.93% | 0.00% | 0.00x | 1.04x | $-80.46 Million |
| 2021 | -25.22% | 0.00% | 0.00x | 1.06x | $-100.18 Million |
| 2022 | -50.48% | 0.00% | 0.00x | 1.09x | $-109.63 Million |
| 2023 | -52.48% | 0.00% | 0.00x | 1.22x | $-141.04 Million |
| 2024 | -100.28% | 0.00% | 0.00x | 1.38x | $-170.59 Million |
Industry Comparison
This section compares Compass Pathways Plc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Compass Pathways Plc (CMPS) | $37.59 Million | 0.00% | 5.80x | $444.83 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |